Roy Winston
2019
In 2019, Roy Winston earned a total compensation of $1.6M as Chief Clinical Officer at Pacira Pharmaceuticals.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $720,919 |
| Salary | $408,654 |
| Stock Awards | $243,824 |
| Other | $13,403 |
| Total | $1,611,800 |
Winston received $720.9K in option awards, accounting for 45% of the total pay in 2019.
Winston also received $225K in bonus, $408.7K in salary, $243.8K in stock awards and $13.4K in other compensation.
Rankings
In 2019, Roy Winston's compensation ranked 6,981st out of 13,971 executives tracked by ExecPay. In other words, Winston earned more than 50.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,981 out of 13,971 | 50th |
Division Manufacturing | 2,670 out of 5,701 | 53rd |
Major group Chemicals And Allied Products | 977 out of 2,200 | 56th |
Industry group Drugs | 826 out of 1,886 | 56th |
Industry Pharmaceutical Preparations | 607 out of 1,398 | 57th |
Pay ratio
| Roy Winston's Pay | $1,611,800 |
|---|---|
| Median Employee's Pay | $155,462 |
| Pay Ratio | 10to 1 |
In 2019, the annual total compensation of Roy Winston was $1,611,800.
The annual total compensation of the median employee at Pacira Pharmaceuticals was $155,462.
The ratio of Roy Winston's pay to the pay of median employee was therefore 10 to one.
Source: SEC filing on April 24, 2020.
Winston's colleagues
We found four more compensation records of executives who worked with Roy Winston at Pacira Pharmaceuticals in 2019.